JPH01500188A - ヘパトーム由来成長因子 - Google Patents

ヘパトーム由来成長因子

Info

Publication number
JPH01500188A
JPH01500188A JP62502601A JP50260187A JPH01500188A JP H01500188 A JPH01500188 A JP H01500188A JP 62502601 A JP62502601 A JP 62502601A JP 50260187 A JP50260187 A JP 50260187A JP H01500188 A JPH01500188 A JP H01500188A
Authority
JP
Japan
Prior art keywords
hdgf
growth factor
derived growth
hepatome
peptide fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP62502601A
Other languages
English (en)
Japanese (ja)
Inventor
スミス，ジョン　エー
Original Assignee
ザ、ゼネラル、ホスピタル、コーポレーション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ザ、ゼネラル、ホスピタル、コーポレーション filed Critical ザ、ゼネラル、ホスピタル、コーポレーション
Publication of JPH01500188A publication Critical patent/JPH01500188A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C07K14/503—Fibroblast growth factor [FGF] basic FGF [bFGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP62502601A 1986-04-08 1987-04-08 ヘパトーム由来成長因子 Pending JPH01500188A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84954186A 1986-04-08 1986-04-08
US849,541 1986-04-08

Publications (1)

Publication Number Publication Date
JPH01500188A true JPH01500188A (ja) 1989-01-26

Family

ID=25305957

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62502601A Pending JPH01500188A (ja) 1986-04-08 1987-04-08 ヘパトーム由来成長因子

Country Status (4)

Country Link
EP (1) EP0241830A3 (de)
JP (1) JPH01500188A (de)
AU (1) AU7301787A (de)
WO (1) WO1987006239A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009022632A1 (ja) * 2007-08-10 2009-02-19 Hyogo College Of Medicine 新規肝癌マーカー

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4956455A (en) * 1984-03-05 1990-09-11 The Salk Institute For Biological Studies Bovine fibroblast growth factor
WO1991006668A1 (en) * 1989-10-27 1991-05-16 The Du Pont Merck Pharmaceutical Company Monoclonal antibodies to basic fibroblast growth factor that inhibit its biological activity
US5281582A (en) * 1992-02-27 1994-01-25 Alliance Pharmaceuticals, Corp. Serum growth factor
CN1431306A (zh) 2002-01-11 2003-07-23 复旦大学 人类肝癌衍生生长因子5、其编码序列、制法及用途

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009022632A1 (ja) * 2007-08-10 2009-02-19 Hyogo College Of Medicine 新規肝癌マーカー

Also Published As

Publication number Publication date
AU7301787A (en) 1987-11-09
EP0241830A3 (en) 1990-01-10
EP0241830A2 (de) 1987-10-21
WO1987006239A1 (en) 1987-10-22

Similar Documents

Publication Publication Date Title
JP2567114B2 (ja) ヒト血管浸透性因子
GONZÁLEZ et al. Two different 8 kDa monomers are involved in the oligomeric organization of the native Echinococcus granulosus antigen B
JP2807660B2 (ja) 悪性−ＰＴＨｒＰの体液性高カルシウム血症において活性的なタンパク質
Quinkler et al. Isolation of heparin‐binding growth factors from bovine, porcine and canine hearts
JP2648951B2 (ja) 人体のソマトメジン担体蛋白質サブユニットとこれらの製法
JPH03500122A (ja) 成長ホルモンレセプター
US4864019A (en) Antibodies to inhibin and conjugates produced therefrom
EP2105447A1 (de) Von vögeln stammender antikörper, der zur spezifischen bindung an humanes hmgb1 fähig ist, immunologisches bestimmungsverfahren für humanes hmgb1, und immunologisches bestimmungsreagens für humanes hmbg1
EP0203587A2 (de) Ras-Oncogene-Peptide und Antikörper
US4882275A (en) Method of purifying endothelial cell growth factors using immobilized heparin
NZ222168A (en) Tumour growth inhibiting protein related to tgf-#b#1 and tgf-#b#2, preparation by genetic engineering methods, antibodies and pharmaceutical compositions
Aston et al. Monoclonal antibodies to growth hormone and prolactin
US4714674A (en) Chemotactic assay for immunogenicity
Bassuk et al. Expression of biologically active human SPARC inEscherichia coli
JPH01500188A (ja) ヘパトーム由来成長因子
EP0629238B1 (de) Autotaxin : ein das selbständige zellbewegungsvermögen stimulierendes protein nützlich in der krebs-diagnostik und therapie
JP2527896B2 (ja) ヒト骨由来インスリン様成長因子結合タンパク
JP3497504B2 (ja) 細胞増殖阻害剤
JPH07173193A (ja) 生物学的活性ポリペプチド類
MacWright et al. Isolation and characterization of pepsin-solubilized human basement membrane (type IV) collagen peptides
Wilson et al. Chromogranin from normal human adrenal glands: purification by monoclonal antibody affinity chromatography and partial N-terminal amino acid sequence
Ziltener et al. Antipeptide antibodies define the NH2-terminal structure of the pan-specific hemopoietin interleukin 3.
US5235042A (en) Endothelial cell growth factor
JPH03163095A (ja) ヒト神経成長因子の部分ペプチド、抗体およびその用途
JP2803184B2 (ja) 酸性線維芽細胞成長因子の抗体，その用途およびペプチド